RYTMONORM 150 MG Israel - English - Ministry of Health

rytmonorm 150 mg

abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

RYTHMEX 150 MG Israel - English - Ministry of Health

rythmex 150 mg

abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

RYTMONORM 300 MG Israel - English - Ministry of Health

rytmonorm 300 mg

abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 300 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

RYTHMEX 300 MG Israel - English - Ministry of Health

rythmex 300 mg

abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 300 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

Propafenone Hydrochloride 300mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

propafenone hydrochloride 300mg film-coated tablets

accord healthcare limited - propafenone hydrochloride - film-coated tablet - 300 milligram(s) - antiarrhythmics, class ic; propafenone

Propafenone Hydrochloride 150mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

propafenone hydrochloride 150mg film-coated tablets

accord healthcare limited - propafenone hydrochloride - film-coated tablet - 150 milligram(s) - antiarrhythmics, class ic; propafenone

Propafenone Hydrochloride 150mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

propafenone hydrochloride 150mg film-coated tablets

accord healthcare ireland ltd. - propafenone hydrochloride - film-coated tablet - 150 milligram(s) - antiarrhythmics, class ic; propafenone

Propafenone Hydrochloride 300mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

propafenone hydrochloride 300mg film-coated tablets

accord healthcare ireland ltd. - propafenone hydrochloride - film-coated tablet - 300 milligram(s) - antiarrhythmics, class ic; propafenone

ARYTHMOL 150 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

arythmol 150 milligram film coated tablet

bgp products ireland limited - propafenone hydrochloride - film coated tablet - 150 milligram - antiarrhythmics, class ic - antiarrhythmics - symptomatic supraventricular tachyarrhythmias requiring treatment, such as av junctional tachycardia, supraventricular tachycardia in patients with wolff-parkinson-white (wpw) syndrome or paroxysmal atrial fibrillation. severe symptomatic ventricular tachyarrhythmia, if the physician considers these to be life-threatening.

ARYTHMOL 300 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

arythmol 300 milligram film coated tablet

bgp products ireland limited - propafenone hydrochloride - film coated tablet - 300 milligram - antiarrhythmics, class ic - antiarrhythmics - symptomatic supraventricular tachyarrhythmias requiring treatment, such as av junctional tachycardias, supraventricular tachycardias in patients with wolff-parkinson-white (wpw) syndrome or paroxysmal atrial fibrillation. severe symptomatic ventricular tachyarrhythmias, if the physician considers these to be life-threatening